Inspire Medical Systems, Inc. revised revenue guidance for the year 2022. For the year, the company is increasing its full year 2022 revenue guidance to between $336 million to $344 million, which would represent growth of 44% to 47% over full year 2021 revenue of $233.4 million. This compares to the prior revenue guidance of $318 million to $326 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
237.4 USD | +2.79% | +3.59% | +16.72% |
Apr. 19 | RBC Initiates Inspire Medical Systems at Outperform With $285 Price Target | MT |
Apr. 18 | Inspire Medical Systems Insider Sold Shares Worth $3,450,450, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.72% | 7.19B | |
+12.07% | 128B | |
-9.04% | 10.65B | |
+0.91% | 8.82B | |
+25.15% | 4.99B | |
+7.17% | 3.4B | |
-1.36% | 3.03B | |
-8.73% | 2.14B | |
-10.15% | 2B | |
-22.81% | 1.79B |
- Stock Market
- Equities
- INSP Stock
- News Inspire Medical Systems, Inc.
- Inspire Medical Systems, Inc. Revises Revenue Guidance for the Year 2022